Scientists have managed to delay the aging (of mice, meanwhile)

Researchers in Tokyo have found that eliminating aging cells inhibits aging-related diseases.

The author of the study claims: An upgraded version of this experimental vaccine could be used "to treat atherosclerosis, diabetes and other diseases"

Shiloni longing

19/12/2021

Sunday, 19 December 2021, 08:00 Updated: 08:42

• Share on Facebook

• Share on WhatsApp

• Share on Twitter

• Share on Email

• Share on general

• Comments

  Comments

Lab Mouse (Photo: ShutterStock)

Scientists are working on a vaccine that stops so-called "zombie cells" associated with human aging.

Preliminary studies done on mice have shown that it works - and can even eliminate serious diseases.

In a study conducted at Jontando University in Tokyo, we examined the process of cell aging, hoping to identify their mechanisms and stop their action.

These cells are found in tissues that have stopped proliferating but refuse to die.

They release chemicals that cause inflammation in the surrounding cells, similar to the way zombies "infect" the humans they come in contact with, hence nicknames.

The process of "zombification", scientifically known as "Senescence", is actually the process of cell aging.

The study found that the elimination of aging cells inhibits the diseases associated with human aging, first by identifying the protein unique to these cells, and then creating a vaccine against it, which will strengthen resistance to it.

More on Walla!

Due to the growing demand for effective pain treatment: B-Cure laser in a special operation

Served on behalf of Bee Cure Laser

Elimination of aging cells inhibits diseases related to human aging (Photo: ShutterStock)

The Japanese researchers gave the experimental vaccine to mice whose arteries hardened in a similar way to the hardening of human arteries as they got older.

They found that the vaccine not only helped improve the condition of the arteries, but also prolonged the life expectancy of mice that had undergone premature aging.

Toro Minamino, author of the study, said that in the future, an upgraded version of this experimental vaccine could be used "to treat atherosclerosis, diabetes and other aging-related diseases."

It may be too early to tell, but these promising research results provide an exciting glimpse into a future where there is an innovative alternative to treating aging-related diseases, and perhaps, for those who want to extend their life expectancy, to treat the "disease" of aging itself.

• technology

• news

Tags

• Mice